Farrell Simon
Chief Commercial Officer at Trevi Therapeutics, Inc. (TRVI) since February 2023
Farrell Simon has filed 12 insider reports with the SEC since February 2023, as director at Serina Therapeutics, Inc. (SER) and chief Commercial Officer at Trevi Therapeutics, Inc. (TRVI). Farrell Simon made no open-market purchases or sales in the last 12 months. The latest filing, on July 23, 2026, reports grant or award at Serina Therapeutics, Inc. (SER).
- Filings
- 12
- Companies
- 2
- Bought on market
- None
- Sold on market
- $549K
Companies where Farrell Simon is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince July 2026 | $1.12 | Jul 23, 2026 | |||||
| Chief Commercial Officersince February 2023 | 76,900 | $549K | $13.35 | Feb 20, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jul 22, 2026SERSEC Form 4 filed by Director Simon FarrellForm 4Grant or award
- Jul 22, 2026SERFarrell Simon became an insiderForm 3New insider
- Feb 19, 2026TRVISEC Form 4 filed by Chief Commercial Officer Simon FarrellForm 4Grant or award
- May 31, 2025TRVISEC Form 4 filed by Chief Commercial Officer Simon FarrellForm 4Grant or award
- Mar 10, 2025-$549KTRVIChief Commercial Officer Simon Farrell exercised 112,563 shares at a strike of $2.86 and sold $548,878 worth of shares (81,313 units at $6.75), increasing direct ownership by 68% to 76,900 unitsForm 4Grant or awardExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Mar 10, 2025~$549KTRVIFarrell Simon plans to sell 81,313 shares (~$549K)Form 144Planned sale10b5-1 plan
- Feb 18, 2025TRVISEC Form 4 filed by Chief Commercial Officer Simon FarrellForm 4Grant or award
- Feb 15, 2024TRVISEC Form 4 filed by Simon FarrellForm 4Grant or award
- Jun 20, 2023TRVISEC Form 4 filed by Simon FarrellForm 4Exercise or conversion of a derivative
- Mar 7, 2023TRVISEC Form 4: Simon Farrell exercised 18,750 shares at a strike of $0.51, increasing direct ownership by 91% to 39,400 unitsForm 4Exercise or conversion of a derivative
- Feb 16, 2023TRVISEC Form 4 filed by Simon FarrellForm 4Grant or award
- Feb 16, 2023TRVISEC Form 3: New insider Simon Farrell claimed ownership of 20,650 sharesForm 3New insider
Compare Farrell Simon with
- Farrell Simon vs Michael Thomas Heffernan1 shared
- Farrell Simon vs Stephen K. Brannan1 shared
- Farrell Simon vs Jay Venkatesan1 shared
- Farrell Simon vs Gregory Bailey1 shared
- Farrell Simon vs Karen J Wilson1 shared
- Farrell Simon vs Richard Peter Marshall1 shared
Other insiders at the same companies
- Michael Thomas HeffernanTRVI
- Stephen K. BrannanSER
- Jay VenkatesanSER
- Gregory BaileySER
- Karen J WilsonSER
- Richard Peter MarshallSER
- Edward T MathersTRVI
- Dominick ColangeloTRVI
- David P MeekerTRVI
- Anne VanlentTRVI
- Steven A LedgerSER
- Srini TenjarlaSER
- Gregory S CurhanSER
- Randall MoreadithSER
- James V CassellaTRVI
- Christopher GallettaTRVI
Questions about Farrell Simon
- What is Farrell Simon's role at Trevi Therapeutics, Inc.?
- Farrell Simon reports to the SEC as chief Commercial Officer at Trevi Therapeutics, Inc. (TRVI), according to the latest filing on February 20, 2026. Farrell Simon has also filed as director at Serina Therapeutics, Inc. (SER).
- How many shares does Farrell Simon own?
- After the latest filing that states it, Farrell Simon directly owned 76,900 shares of Trevi Therapeutics, Inc. (TRVI). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Farrell Simon bought or sold stock recently?
- The most recent open-market sale was on March 10, 2025: sold 81,313 shares of Trevi Therapeutics, Inc. (TRVI) for $549K at an average of $6.75.
- How do I get alerts when Farrell Simon files?
- Follow Farrell Simon on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Farrell Simon (SEC CIK 0001965585). Totals count each trade once, skipping amendments whose original is on file, from Feb 16, 2023 on. View on SEC EDGAR · Get this as JSON